Interleukin 2 increases CD4 T cell counts in people with HIVBMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7255.196/a (Published 22 July 2000) Cite this as: BMJ 2000;321:196
- Deborah Josefson
- San Francisco
Adding interleukin 2 to antiretroviral drugs substantially increases the CD4 T cell count and decreases the viral load of HIV, according to a multicentre trial sponsored by the National Institutes for Health (JAMA 2000;284:183-9).
The combination treatment may further extend the immune competency and therefore the life span of people infected with HIV. The two year study, led by Drs …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial